Evaluation of Low-thermal Argon Plasma Devitalization for the Treatment of CIN 2 Versus Standard of Active Surveillance
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The study aims to show that treatment with LtAPD works better than a sham treatment or simply monitoring the condition closely without active treatment ("active surveillance"), in achieving complete healing of a tissue abnormality on the cervix called CIN 2, after 6 months. This will be confirmed by examining tissue samples under a microscope (histopathological examination).
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Kobiety w wieku 18-40 lat.
- •Zmiana CIN 2 potwierdzona w badaniu histopatologicznym.
- •Lekarz widzi całą podejrzaną strefę i zmianę podczas badania wziernikiem (kolposkopii).
- •Pacjentka rozumie badanie i świadomie wyraża zgodę na udział.
✗ Disqualifies
- •Inne zmiany w szyjce macicy niż CIN 2 lub podejrzenie raka.
- •Zmiany sięgające do sklepienia pochwy lub podejrzenie choroby w kanale szyjki macicy.
- •Ciąża lub planowanie ciąży w ciągu najbliższych 6 miesięcy.
- •Silne zapalenie lub aktywna infekcja w miejscu badania.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 40 Years
- Last updated (source)
- October 1, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (1)
University Hospital Tuebingen, Department of Women's Health
Tübingen, Germany
Trial contact
Martin Weiss, Prof. Dr.
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/2/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.